Skip to main content
Erschienen in: Drug Safety 10/2009

01.10.2009 | Original Research Article

Reporting of Adverse Drug Reactions by General Practitioners

A Questionnaire-Based Study in the Netherlands

verfasst von: Anneke Passier, PhD, Marije ten Napel, Kees van Grootheest, Eugène van Puijenbroek

Erschienen in: Drug Safety | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

Background: There has been a gradual decline over the years in the number of spontaneous reports of potential adverse drug reactions (ADRs) from general practitioners (GPs) in the Netherlands.
Objective: To reveal aspects of knowledge, attitudes and behaviour that can stimulate GPs to submit (more) ADRs.
Methods: Dutch GPs were divided into the following two groups based on their reporting behaviour during the period 2004–6: (i) active reporters; and (ii) non-reporters. A random selection from each group was sent a questionnaire, based on the Ajzen and Fishbein model, focussed on their reporting behaviour. The questions were subdivided into knowledge-related questions, attitude-related questions and questions about the influence of the professional environment.
Results: 700 questionnaires were completed, corresponding with an overall response of 47%. GPs who actively reported ADRs differed from their non-reporting colleagues: they had more knowledge on ADR reporting, were more interested in pharmacotherapy and more often had a positive example in their professional environment. Both reporting and non-reporting GPs considered it very important to comply with their professional environment.
Conclusion: Specific education and training of GPs on pharmacotherapy, preferably with extra attention to ADR reporting, is expected to improve ADR reporting. Improved communication of GPs with their fellow GPs and pharmacists as well as with their patients may further stimulate ADR reporting.
Literatur
1.
Zurück zum Zitat BMA Board of Science. Reporting adverse drug reactions: a guide for health care professionals. London: BMA Board of Science, 2006 BMA Board of Science. Reporting adverse drug reactions: a guide for health care professionals. London: BMA Board of Science, 2006
2.
Zurück zum Zitat WHO. The importance of pharmacovigilance. Geneva: WHO, 2002 WHO. The importance of pharmacovigilance. Geneva: WHO, 2002
3.
Zurück zum Zitat Martin RM, Kapoor KV, Wilton LV, et al. Underreporting of suspected adverse drug reactions to newly marketed (‘black triangle’) drugs in general practice: observational study. BMJ 1998; 11(317): 119–20CrossRef Martin RM, Kapoor KV, Wilton LV, et al. Underreporting of suspected adverse drug reactions to newly marketed (‘black triangle’) drugs in general practice: observational study. BMJ 1998; 11(317): 119–20CrossRef
4.
Zurück zum Zitat Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29(5): 385–96PubMedCrossRef Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29(5): 385–96PubMedCrossRef
6.
Zurück zum Zitat Inman WHW. Assessment drug safety problems. In: Gent M, Shigmatsu I, editors. Epidemiological issues in reported drug-induced illnesses. Hamilton (ON): McMaster Uni-versity Library Press, 1976: 17–24 Inman WHW. Assessment drug safety problems. In: Gent M, Shigmatsu I, editors. Epidemiological issues in reported drug-induced illnesses. Hamilton (ON): McMaster Uni-versity Library Press, 1976: 17–24
7.
Zurück zum Zitat Eland IA, Belton KJ, van Grootheest AC, et al. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 1999; 48: 623–7PubMedCrossRef Eland IA, Belton KJ, van Grootheest AC, et al. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 1999; 48: 623–7PubMedCrossRef
8.
Zurück zum Zitat van Grootheest AC, van Puijenbroek EP. Pharmacovigilance in the Netherlands. In: Mann R, Andrews E, editors. Pharmacovigilance. Chichester: Wiley and Sons, 2007 van Grootheest AC, van Puijenbroek EP. Pharmacovigilance in the Netherlands. In: Mann R, Andrews E, editors. Pharmacovigilance. Chichester: Wiley and Sons, 2007
9.
Zurück zum Zitat Wallerstedt SM, Brunlöf G, Johansson ML, et al. Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor. Eur J Clin Pharmacol 2007 May; 63(5): 505–8PubMedCrossRef Wallerstedt SM, Brunlöf G, Johansson ML, et al. Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor. Eur J Clin Pharmacol 2007 May; 63(5): 505–8PubMedCrossRef
10.
Zurück zum Zitat Ekman E. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol 2009; 65(1): 43–6PubMedCrossRef Ekman E. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden. Eur J Clin Pharmacol 2009; 65(1): 43–6PubMedCrossRef
11.
Zurück zum Zitat Cox AR, Marriott JF, Wilson KA, et al. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther 2004; 29: 31–5PubMedCrossRef Cox AR, Marriott JF, Wilson KA, et al. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther 2004; 29: 31–5PubMedCrossRef
12.
Zurück zum Zitat Ajzen I, Fishbein M. Understanding attitudes and predicting social behaviour. Englewood Cliffs (NJ): Prentice Hall, 1980 Ajzen I, Fishbein M. Understanding attitudes and predicting social behaviour. Englewood Cliffs (NJ): Prentice Hall, 1980
13.
Zurück zum Zitat Herdeiro MT, Polonia J, Gestal-Otero JJ, et al. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional. J Eval Clin Pract 2004; 10: 483–9PubMedCrossRef Herdeiro MT, Polonia J, Gestal-Otero JJ, et al. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional. J Eval Clin Pract 2004; 10: 483–9PubMedCrossRef
14.
Zurück zum Zitat Hasford J, Goettler M, Munter KH, et al. Physicians’ knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 2002; 55: 945–50PubMedCrossRef Hasford J, Goettler M, Munter KH, et al. Physicians’ knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 2002; 55: 945–50PubMedCrossRef
15.
Zurück zum Zitat Herdeiro MT, Figueiras A, Polónia J, et al. Physicians’ attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2005; 28(9): 825–33PubMedCrossRef Herdeiro MT, Figueiras A, Polónia J, et al. Physicians’ attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2005; 28(9): 825–33PubMedCrossRef
16.
Zurück zum Zitat Figueiras A, Tato F, Fontaiñas J, et al. Influence of physicians’ attitudes on reporting adverse drug events: a case-control study. Med Care 1999 Aug; 37(8): 809–1PubMedCrossRef Figueiras A, Tato F, Fontaiñas J, et al. Influence of physicians’ attitudes on reporting adverse drug events: a case-control study. Med Care 1999 Aug; 37(8): 809–1PubMedCrossRef
17.
Zurück zum Zitat Figueiras A, Herdeiro MT, Polónia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006; 296: 1086–93PubMedCrossRef Figueiras A, Herdeiro MT, Polónia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006; 296: 1086–93PubMedCrossRef
18.
Zurück zum Zitat Maxwell S, Walley T. Teaching safe and effective prescribing in UK medical schools: a core curriculum for tomorrow’s doctors. Br J Clin Pharmacol 2003; 55: 496–503PubMedCrossRef Maxwell S, Walley T. Teaching safe and effective prescribing in UK medical schools: a core curriculum for tomorrow’s doctors. Br J Clin Pharmacol 2003; 55: 496–503PubMedCrossRef
Metadaten
Titel
Reporting of Adverse Drug Reactions by General Practitioners
A Questionnaire-Based Study in the Netherlands
verfasst von
Anneke Passier, PhD
Marije ten Napel
Kees van Grootheest
Eugène van Puijenbroek
Publikationsdatum
01.10.2009
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 10/2009
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.2165/11314490-000000000-00000

Weitere Artikel der Ausgabe 10/2009

Drug Safety 10/2009 Zur Ausgabe